MeSH term
Frequency | Condition_Probility | Animals | 130 | 0.0 |
Cell Line | 11 | 0.0 |
Hamsters | 12 | 0.0 |
Humans | 220 | 0.0 |
Rabbits | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 149 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 26 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Adult | 65 | 0.0 |
Female | 95 | 0.0 |
Male | 116 | 0.0 |
Middle Aged | 48 | 0.0 |
Postoperative Period | 2 | 0.0 |
Radioimmunoassay | 21 | 1.0 |
Time Factors | 17 | 0.0 |
Cell Division/drug effects | 5 | 0.0 |
Peptide YY/pharmacology | 5 | 55.0 |
Arcuate Nucleus/metabolism | 2 | 33.0 |
Binding, Competitive/drug effects | 2 | 3.0 |
Chickens | 3 | 0.0 |
Cloning, Molecular | 19 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
Ligands | 5 | 0.0 |
Molecular Sequence Data | 40 | 0.0 |
Naphthalenes/pharmacology | 2 | 2.0 |
Phylogeny | 7 | 0.0 |
Pyrrolidines/pharmacology | 2 | 4.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Sequence Homology, Amino Acid | 20 | 0.0 |
Transfection | 7 | 0.0 |
Amino Acid Sequence | 44 | 0.0 |
Base Sequence | 14 | 0.0 |
COS Cells | 3 | 0.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Neuropeptide Y/*metabolism | 9 | 12.0 |
Pancreatic Polypeptide/*metabolism | 5 | 45.0 |
Peptide YY/*metabolism | 5 | 71.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Receptors, Neuropeptide Y/genetics/*metabolism | 4 | 50.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Tissue Distribution | 9 | 0.0 |
Aged | 28 | 0.0 |
Cell Division | 2 | 0.0 |
Cyclic AMP/metabolism | 9 | 1.0 |
Peptide YY/*genetics/*metabolism | 2 | 100.0 |
Brain/metabolism | 3 | 0.0 |
Rats | 55 | 0.0 |
Digestive System/metabolism | 3 | 15.0 |
Models, Biological | 4 | 0.0 |
Neurons/metabolism | 2 | 0.0 |
Calcium/metabolism | 3 | 0.0 |
Gastric Acid/*secretion | 8 | 13.0 |
Gastric Mucosa/metabolism | 2 | 4.0 |
Protein Binding | 3 | 0.0 |
Digestive System/*metabolism | 3 | 7.0 |
Fermentation | 2 | 5.0 |
Gastrins/metabolism | 3 | 15.0 |
Intestines/metabolism | 3 | 2.0 |
Evolution, Molecular | 2 | 0.0 |
Gene Duplication | 2 | 1.0 |
Species Specificity | 8 | 0.0 |
*Aging | 2 | 1.0 |
Cell Differentiation | 2 | 0.0 |
Colon/metabolism | 2 | 1.0 |
Mice | 27 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 13 | 0.0 |
Appetite Regulation/*physiology | 3 | 21.0 |
Case-Control Studies | 6 | 0.0 |
Cholecystokinin/blood | 7 | 13.0 |
Dietary Fats/*pharmacology | 2 | 3.0 |
Peptide YY/*blood | 3 | 100.0 |
Protein Conformation | 3 | 0.0 |
Administration, Oral | 2 | 0.0 |
Cholecystokinin/*blood | 2 | 2.0 |
Glucagon/*blood | 2 | 11.0 |
Insulin/blood | 2 | 0.0 |
Peptide Fragments/*blood | 2 | 2.0 |
Peptide YY/blood | 9 | 90.0 |
Protein Precursors/*blood | 2 | 2.0 |
Image Processing, Computer-Assisted | 4 | 1.0 |
Immunohistochemistry | 17 | 0.0 |
Peptide YY/metabolism | 6 | 50.0 |
Rats, Sprague-Dawley | 14 | 0.0 |
Rats, Wistar | 10 | 0.0 |
Electrophysiology | 4 | 0.0 |
*Gastric Emptying | 3 | 30.0 |
Gastrointestinal Hormones/*blood | 6 | 6.0 |
Glucagon/blood | 3 | 3.0 |
Motilin/blood | 2 | 11.0 |
Peptide Fragments/blood | 3 | 2.0 |
Postprandial Period | 4 | 4.0 |
Protein Precursors/blood | 3 | 8.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Comparative Study | 46 | 0.0 |
Molecular Weight | 4 | 0.0 |
Peptide Fragments/*metabolism | 6 | 4.0 |
Receptors, Cell Surface/*metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 21 | 0.0 |
Child | 5 | 0.0 |
English Abstract | 4 | 0.0 |
Adaptation, Physiological | 2 | 2.0 |
Intestinal Mucosa/chemistry | 2 | 7.0 |
Intestines/*metabolism | 2 | 2.0 |
Peptide YY/chemistry/*metabolism | 2 | 100.0 |
Phosphorylation | 2 | 0.0 |
Swine | 16 | 1.0 |
Analysis of Variance | 4 | 0.0 |
Dose-Response Relationship, Drug | 17 | 0.0 |
Injections, Intraventricular | 3 | 2.0 |
Structure-Activity Relationship | 8 | 0.0 |
Intestine, Small/physiology | 2 | 50.0 |
Pancreatic Polypeptide/blood | 4 | 6.0 |
Colon/pathology | 2 | 4.0 |
Gastrointestinal Motility/*physiology | 6 | 37.0 |
Pressure | 2 | 1.0 |
CHO Cells | 9 | 0.0 |
Peptide Fragments/metabolism | 2 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Fishes | 5 | 6.0 |
Mammals | 2 | 0.0 |
Peptide YY/chemistry/*genetics | 2 | 100.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Sequence Alignment | 9 | 0.0 |
Xenopus laevis | 2 | 0.0 |
Adolescent | 12 | 0.0 |
Gastrointestinal Hormones/*secretion | 3 | 7.0 |
*Gastrointestinal Motility | 2 | 20.0 |
Receptors, Gastrointestinal Hormone/*physiology | 3 | 60.0 |
Peptides/*chemistry | 2 | 4.0 |
Neuropeptide Y/pharmacology | 3 | 13.0 |
Pancreatic Polypeptide/pharmacology | 7 | 70.0 |
*Multigene Family | 2 | 0.0 |
Neuropeptide Y/chemistry/*genetics | 2 | 66.0 |
Zebrafish/*genetics | 2 | 7.0 |
Cattle | 7 | 0.0 |
Receptors, Neuropeptide Y/*antagonists & inhibitors/physiology | 2 | 66.0 |
Arginine/analogs & derivatives/pharmacology | 5 | 16.0 |
Binding Sites | 8 | 0.0 |
Cell Membrane/metabolism | 10 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Guanosine 5'-O-(3-Thiotriphosphate)/metabolism | 2 | 2.0 |
*Lipolysis | 2 | 6.0 |
Peptides/metabolism | 13 | 5.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Gastric Emptying/*drug effects | 3 | 23.0 |
Infusions, Intravenous | 4 | 0.0 |
Peptide YY/*pharmacology | 7 | 100.0 |
*Pharmacology | 2 | 50.0 |
Electric Stimulation | 5 | 2.0 |
Receptors, Neuropeptide Y/*metabolism | 3 | 13.0 |
Colon/*metabolism | 2 | 3.0 |
Reference Values | 6 | 0.0 |
Models, Molecular | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Radioligand Assay | 4 | 0.0 |
Vasoactive Intestinal Peptide/pharmacology | 7 | 8.0 |
Autoradiography | 6 | 1.0 |
In Vitro | 14 | 0.0 |
Iodine Radioisotopes/diagnostic use | 3 | 0.0 |
Kinetics | 12 | 0.0 |
Pancreatic Polypeptide/metabolism | 8 | 38.0 |
Receptors, Neuropeptide Y/antagonists & inhibitors/*metabolism | 2 | 66.0 |
Gastrointestinal Transit/physiology | 2 | 33.0 |
Peptide YY/*physiology | 2 | 100.0 |
Neuropeptide Y/metabolism | 6 | 9.0 |
Pancreatic Neoplasms/*drug therapy/pathology | 2 | 20.0 |
Biopsy | 4 | 0.0 |
Endocrine Cells of Gut/*pathology | 4 | 100.0 |
Serotonin/metabolism | 3 | 3.0 |
Colon/*chemistry | 2 | 9.0 |
Disease Models, Animal | 2 | 0.0 |
Galanin/analysis | 2 | 20.0 |
Mice, Inbred NOD | 3 | 1.0 |
Neuropeptide Y/analysis | 3 | 4.0 |
Neuropeptides/*analysis | 4 | 5.0 |
Neurotensin/analysis | 2 | 20.0 |
Peptide YY/analysis | 4 | 80.0 |
Somatostatin/analysis | 6 | 10.0 |
Vasoactive Intestinal Peptide/analysis | 4 | 4.0 |
Blotting, Southern | 3 | 0.0 |
Cyclic AMP/biosynthesis | 3 | 2.0 |
Guinea Pigs | 5 | 0.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Dogs | 9 | 0.0 |
Duodenum/*physiology | 2 | 18.0 |
Fasting | 2 | 0.0 |
Age Factors | 3 | 0.0 |
Enteroglucagon/analysis | 3 | 50.0 |
Serotonin/analysis | 4 | 16.0 |
Colon/*pathology | 2 | 12.0 |
Duodenal Diseases/pathology | 2 | 100.0 |
Image Interpretation, Computer-Assisted | 2 | 20.0 |
Myotonic Dystrophy/complications/*pathology | 2 | 100.0 |
Rectal Diseases/pathology | 2 | 100.0 |
Aged, 80 and over | 5 | 0.0 |
Duodenum | 2 | 8.0 |
Glucose/pharmacology | 2 | 1.0 |
Intracellular Membranes/metabolism | 2 | 1.0 |
Mice, Nude | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Osmolar Concentration | 6 | 0.0 |
Anura | 2 | 13.0 |
Blood Pressure/*drug effects/physiology | 2 | 15.0 |
Biological Markers | 4 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Cross-Over Studies | 5 | 0.0 |
Gastric Emptying/*physiology | 2 | 33.0 |
Gastrointestinal Hormones/metabolism | 5 | 71.0 |
Intestinal Absorption | 2 | 1.0 |
Reproducibility of Results | 2 | 0.0 |
Galanin/metabolism | 2 | 25.0 |
Neuropeptides/*metabolism | 3 | 3.0 |
Somatostatin/metabolism | 2 | 4.0 |
Vasoactive Intestinal Peptide/metabolism | 2 | 2.0 |
Cohort Studies | 2 | 0.0 |
Follow-Up Studies | 4 | 0.0 |
Retrospective Studies | 4 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
Neuropeptide Y/analogs & derivatives/*pharmacology | 3 | 60.0 |
Peptide Fragments/*pharmacology | 3 | 1.0 |
Peptides, Cyclic/*pharmacology | 2 | 9.0 |
Jejunum/*metabolism | 2 | 16.0 |
Mice, Transgenic | 2 | 0.0 |
Neuropeptide Y/genetics/metabolism | 2 | 33.0 |
Neuropeptide Y/*pharmacology | 6 | 9.0 |
Peptide Fragments/pharmacology | 4 | 1.0 |
Peptides/pharmacology | 8 | 4.0 |
Receptors, Gastrointestinal Hormone/*metabolism | 3 | 11.0 |
Stimulation, Chemical | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
GTP-Binding Proteins/metabolism | 3 | 1.0 |
Pertussis Toxin | 3 | 1.0 |
Colon/metabolism/pathology | 2 | 13.0 |
Myoelectric Complex, Migrating/*physiology | 2 | 50.0 |
Chromatography, Gel | 6 | 0.0 |
Chromatography, High Pressure Liquid | 5 | 0.0 |
Peptide YY/*analysis | 2 | 100.0 |
Pregnancy | 5 | 0.0 |
Pancreatic Polypeptide/*physiology | 2 | 100.0 |
Gastrointestinal Hormones/*metabolism | 7 | 29.0 |
Peptides/*metabolism | 12 | 6.0 |
Arginine/*analogs & derivatives/pharmacology | 5 | 31.0 |
Forskolin/pharmacology | 4 | 1.0 |
Adenylate Cyclase/metabolism | 2 | 1.0 |
Neuropeptide Y/metabolism/*physiology | 2 | 33.0 |
Binding, Competitive | 10 | 0.0 |
Neuropeptide Y/*analogs & derivatives/pharmacology | 2 | 66.0 |
Receptors, Neuropeptide Y/*antagonists & inhibitors | 2 | 15.0 |
Receptors, Neuropeptide Y/chemistry/genetics | 2 | 100.0 |
Ileum/*physiology | 2 | 66.0 |
Peptide YY | 95 | 82.0 |
Double-Blind Method | 3 | 0.0 |
Eating | 4 | 2.0 |
Injections, Intravenous | 3 | 0.0 |
Peptides/blood/*pharmacology | 5 | 71.0 |
Eating/*physiology | 3 | 4.0 |
Adrenergic alpha-Agonists/pharmacology | 3 | 12.0 |
Chlorides/*metabolism | 2 | 2.0 |
Clonidine/pharmacology | 2 | 13.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
Depression, Chemical | 2 | 1.0 |
Epithelium/drug effects/metabolism | 2 | 3.0 |
Pancreatic Polypeptide/*pharmacology | 2 | 28.0 |
Patch-Clamp Techniques | 2 | 0.0 |
Receptors, Gastrointestinal Hormone/drug effects/*metabolism | 2 | 33.0 |
Somatostatin/*pharmacology | 3 | 6.0 |
*Digestive Physiology | 3 | 9.0 |
Chromosome Mapping | 2 | 0.0 |
Organ Specificity | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Brain/*metabolism | 4 | 0.0 |
*Evolution | 4 | 2.0 |
Hypothalamus/metabolism | 2 | 4.0 |
Substrate Specificity | 2 | 0.0 |
Gastrointestinal Hormones/blood | 2 | 40.0 |
Peptides/blood | 3 | 8.0 |
Iodine Radioisotopes | 6 | 1.0 |
Somatostatin/pharmacology | 2 | 4.0 |
Tetrodotoxin/pharmacology | 2 | 5.0 |
Gene Expression | 5 | 0.0 |
Peptides/genetics/*physiology | 2 | 16.0 |
Gastrointestinal Hormones/pharmacology | 5 | 55.0 |
Peptides/*pharmacology | 10 | 4.0 |
Cell Membrane Permeability | 2 | 1.0 |
Chromogranins/analysis | 3 | 5.0 |
Constipation/etiology | 2 | 66.0 |
Pancreatic Polypeptide/*analysis | 4 | 44.0 |
Gastrointestinal Hormones/*pharmacology | 5 | 17.0 |
Pancreatic Neoplasms/*pathology | 2 | 5.0 |
Cyclic AMP/analysis | 2 | 8.0 |
Receptors, Gastrointestinal Hormone/classification/*genetics/metabolism | 2 | 100.0 |
Receptors, Neuropeptide Y/classification/*genetics/metabolism | 2 | 100.0 |
Substance P/analysis | 2 | 2.0 |
Receptors, Neuropeptide Y/metabolism | 2 | 15.0 |
Secretory Rate/drug effects | 2 | 2.0 |
Sensitivity and Specificity | 3 | 0.0 |
Body Weight | 2 | 0.0 |
Glucagon/*metabolism | 2 | 66.0 |
Protein Precursors/*metabolism | 2 | 2.0 |
Neuropeptide Y/*genetics | 2 | 6.0 |
Blood Pressure/drug effects | 2 | 0.0 |
Adipose Tissue/drug effects/*metabolism | 2 | 12.0 |
Neuroblastoma/*metabolism/pathology | 2 | 5.0 |
Virulence Factors, Bordetella/pharmacology | 2 | 1.0 |
Neuropeptide Y/*analysis | 2 | 4.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Gastrins/blood | 2 | 2.0 |
Somatostatin/blood | 2 | 8.0 |
Cross Reactions | 4 | 0.0 |
Peptides/*blood | 5 | 7.0 |
Peptide Biosynthesis | 2 | 4.0 |
Neuroblastoma | 3 | 1.0 |
Neuropeptide Y/*analogs & derivatives/metabolism/*pharmacology | 2 | 100.0 |
Intestinal Mucosa/drug effects/*metabolism | 3 | 42.0 |
Gastric Emptying/physiology | 2 | 11.0 |
Peptides/*blood/physiology | 2 | 100.0 |
Child, Preschool | 3 | 0.0 |
Glucagon/analysis | 2 | 11.0 |
Immunoenzyme Techniques | 4 | 0.0 |
Infant | 4 | 0.0 |
Peptides/analysis | 4 | 5.0 |
Receptors, Cell Surface/metabolism | 2 | 0.0 |
Receptors, Neuropeptide Y | 15 | 45.0 |
Receptors, Neurotransmitter/*metabolism | 7 | 25.0 |
Eating/physiology | 2 | 3.0 |
Energy Intake | 2 | 1.0 |
Infant, Newborn | 2 | 0.0 |
Gastrointestinal Motility/*drug effects | 4 | 18.0 |
Vagotomy | 2 | 14.0 |
Gastrointestinal Hormones/*physiology | 2 | 13.0 |
Pentagastrin/pharmacology | 2 | 18.0 |
Peptides/*physiology | 2 | 4.0 |
Rats, Inbred Strains | 6 | 0.0 |
Neuroblastoma/*metabolism | 2 | 3.0 |
Bulimia/*metabolism/physiopathology | 2 | 100.0 |
Feeding Behavior/physiology | 2 | 15.0 |
Affinity Labels | 2 | 3.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Gastrin-Releasing Peptide | 2 | 2.0 |
Isoproterenol/pharmacology | 2 | 1.0 |
Cell Count | 2 | 0.0 |
Gastrointestinal Hormones/analysis | 2 | 50.0 |
Microscopy, Electron | 4 | 0.0 |
Norepinephrine/pharmacology | 2 | 2.0 |
Regional Blood Flow/drug effects | 2 | 1.0 |
Peptides/administration & dosage/blood/*pharmacology | 2 | 40.0 |
Hippocampus/metabolism | 2 | 2.0 |
Colon/analysis | 2 | 50.0 |
Peptides/*cerebrospinal fluid | 2 | 66.0 |
Macaca mulatta | 2 | 0.0 |
Duodenum/analysis | 2 | 16.0 |
Gastrointestinal Hormones/*analysis | 3 | 10.0 |
Histocytochemistry | 9 | 1.0 |
Intestine, Small/analysis | 2 | 66.0 |
Peptides/*analysis | 7 | 10.0 |
Blood Pressure/*drug effects | 2 | 1.0 |
Immunologic Techniques | 2 | 0.0 |
Immunochemistry | 4 | 1.0 |
Nerve Tissue Proteins/*pharmacology | 2 | 2.0 |
Neuropeptide Y | 4 | 8.0 |
Glucagon/*analysis | 3 | 50.0 |
Aging | 2 | 0.0 |
Chromatography, High Pressure Liquid/methods | 2 | 1.0 |
Endocrine Glands/*analysis/cytology | 2 | 100.0 |
Fetus/analysis | 2 | 28.0 |
Intestines/*analysis/cytology | 2 | 100.0 |
Islets of Langerhans/*analysis/cytology | 2 | 100.0 |
Protein Precursors/analysis | 2 | 4.0 |
Ranidae | 2 | 8.0 |
Turtles | 2 | 28.0 |
Mice, Knockout | 2 | 0.0 |
